Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the industrial and healthcare sectors, announced that it has finalized the acquisition of seven European pharmaceutical manufacturing facilities from Recipharm, a leading contract development and manufacturing organization (“CDMO”). The seven facilities acquired from Recipharm are Solna, Stängnäs, Höganäs, Karlskoga and Uppsala OTC Development in Sweden, Pessac in France, and Parets in Spain. In addition, Blue Wolf has also agreed, subject to regulatory clearances, to acquire Synerlab, a CDMO headquartered in Strasbourg, France, with six operating facilities in France and Spain.
Read the full article: Blue Wolf Capital to Create New CDMO Platform //
Source: https://www.businesswire.com/news/home/20240925679693/en/Blue-Wolf-Capital-to-Create-New-CDMO-Platform